MRI also delineates a third phase of neurodevelopment in this model, which occurs from the fifth to seventh week of postnatal life. During this phase, myelination and a reversal of gray/white ...

Horizon Therapeutics Plc presented positive new MRI data from the phase 3 clinical trial of UPLIZNA (inebilizumab) at the 9th Congress of the European Academy of Neurology (EAN) in Budapest ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing an ...

QUANTI Pediatric assessed the pharmacokinetics and safety of gadoquatrane in children from birth to < 18 years of age undergoing contrast-enhanced MRI. The design and dosing of the Phase III ...